Operating Lease, Right-of-Use Asset of BICYCLE THERAPEUTICS PLC from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BICYCLE THERAPEUTICS PLC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • BICYCLE THERAPEUTICS PLC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,562,000, a 50% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BICYCLE THERAPEUTICS PLC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,562,000 -$4,530,000 -50% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $5,806,000 -$5,127,000 -47% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $6,712,000 -$5,313,000 -44% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $7,673,000 -$5,496,000 -42% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $9,092,000 -$5,505,000 -38% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $10,933,000 -$5,089,000 -32% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $12,025,000 -$6,696,000 -36% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $13,169,000 -$489,000 -3.6% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $14,597,000 +$1,113,000 +8.3% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $16,022,000 +$946,000 +6.3% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $18,721,000 +$1,971,000 +12% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $13,658,000 -$1,008,000 -6.9% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $13,484,000 +$10,238,000 +315% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $15,076,000 +$11,548,000 +327% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $16,750,000 +$13,029,000 +350% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $14,666,000 +$13,376,000 +1037% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $3,246,000 +$1,787,000 +122% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $3,528,000 +$1,901,000 +117% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $3,721,000 +$1,906,000 +105% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $1,290,000 -$766,000 -37% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $1,459,000 -$718,000 -33% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $1,627,000 -$759,000 -32% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $1,815,000 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $2,056,000 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $2,177,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $2,386,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.